☆ 4.7 Review

Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke A Systematic Review and Meta-analysis

JAMA NETWORK OPEN (2022)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion

Fana Alemseged et al.

Summary: The study showed that the use of TNK prior to EVT in patients with BAO may lead to higher rates of reperfusion compared to alteplase. Randomized controlled trials comparing TNK with alteplase in BAO patients are needed to further validate these findings.

NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Tenecteplase for Acute Ischemic Stroke Treatment

Alison E. Baird et al.

Summary: The introduction of thrombolytic therapy in the 1990s revolutionized the treatment of acute ischemic stroke, with tenecteplase (TNK) emerging as a potential replacement for alteplase (rt-PA) due to its superior fibrin specificity, slower clearance, and resistance to inhibitors. Although TNK has shown similar efficacy and safety to rt-PA in clinical trials, further studies are needed to determine its potential advantages in improving clinical outcomes.

SEMINARS IN NEUROLOGY (2021)

Add to Collection

Review Clinical Neurology

Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions Systematic Review and Meta-Analysis

Aristeidis H. Katsanos et al.

Summary: The study found that acute ischemic stroke patients with large vessel occlusions receiving intravenous thrombolysis with tenecteplase had significantly better recanalization and clinical outcomes compared to patients receiving alteplase.

STROKE (2021)

Add to Collection

Article Clinical Neurology

Functional Outcome, Recanalization, and Hemorrhage Rates After Large Vessel Occlusion Stroke Treated With Tenecteplase Before Thrombectomy

Gaspard Gerschenfeld et al.

Summary: The use of tenecteplase before mechanical thrombectomy in patients with large vessel occlusion acute ischemic strokes is safe, effective, and achieves fast recanalization, leading to improved functional independence in routine care settings.

NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke

Cathy S. Zhong et al.

Summary: The routine use of tenecteplase for stroke thrombolysis is feasible and has comparable safety profile and outcomes to alteplase.

STROKE (2021)

Add to Collection

Meeting Abstract Clinical Neurology

Results of a Prospective Observational Cohort Study of Tenecteplase as Standard of Care Stroke Thrombolytic

Steven J. Warach et al.

STROKE (2021)

Add to Collection

Editorial Material Clinical Neurology

Should Tenecteplase be Given in Clinical Practice for Acute Ischemic Stroke Thrombolysis?

Jukka Putaala et al.

STROKE (2021)

Add to Collection

Article Clinical Neurology

Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes Consensus Recommendations From Stroke Therapy Academic Industry Roundtable XI

Jeffrey L. Saver et al.

Summary: The modified Rankin Scale (mRS) is widely used in acute stroke trials as a measure of global disability. Recent efforts have been made to modernize the scale by providing recommended rubrics for describing the distinctive outcomes, aiming to enhance understanding among clinicians, patients, and stakeholders across trials.

STROKE (2021)

Add to Collection

Article Clinical Neurology

Switching to Tenecteplase for Stroke Thrombolysis Real-World Experience and Outcomes in a Regional Stroke Network

Karim Mahawish et al.

Summary: The switch from alteplase to tenecteplase for stroke thrombolysis was successfully implemented with stakeholder endorsement. Patients treated with tenecteplase showed better clinical outcomes, shorter door-to-needle time, and similar complication rates compared to alteplase.

STROKE (2021)

Add to Collection

Review Clinical Neurology

Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence

Georgios Tsivgoulis et al.

Summary: Intravenous thrombolysis (IVT) is the only systemic reperfusion therapy that can reverse neurological deficits in patients with acute ischemic stroke (AIS), but its use is limited due to short therapeutic windows and contraindications. Recent research suggests that off-label use of IVT is becoming more common, with extensions of therapeutic time windows and expanded indications in co-existing conditions.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)

Add to Collection

Article Clinical Neurology

European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke

Eivind Berge et al.

Summary: Intravenous thrombolysis is the approved systemic reperfusion treatment for acute ischaemic stroke patients, with the ESO guidelines providing evidence-based recommendations. The guidelines highlight the importance of timely thrombolysis within 4.5 hours for improving functional outcomes, and recommend its use for specific patient subgroups such as those waking from sleep.

EUROPEAN STROKE JOURNAL (2021)

Add to Collection

Article Clinical Neurology

Real-world comparative safety and efficacy of tenecteplase versus alteplase in acute ischemic stroke patients with large vessel occlusion

Klearchos Psychogios et al.

Summary: The study compared the safety and efficacy of intravenous tenecteplase with alteplase in AIS patients with LVO. While early neurological improvement was slightly better in the tenecteplase group, there were no significant differences in other outcomes between the two groups, highlighting the need for further research confirmation.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)

Add to Collection

Article Medicine, General & Internal

Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke The EXTEND-IA TNK Part 2 Randomized Clinical Trial

Bruce C. V. Campbell et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Review Clinical Neurology

Tenecteplase Thrombolysis for Acute Ischemic Stroke

Steven J. Warach et al.

STROKE (2020)

Add to Collection

Article Clinical Neurology

Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials

Adrian M. Burgos et al.

STROKE (2019)

Add to Collection

Letter Clinical Neurology

Recanalization before Thrombectomy in Tenecteplase vs. Alteplase-Treated Drip-and-Ship Patients

Pierre Seners et al.

JOURNAL OF STROKE (2019)

Add to Collection

Review Clinical Neurology

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

William J. Powers et al.

STROKE (2019)

Add to Collection

Article Clinical Neurology

Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study

Bruce C. V. Campbell et al.

INTERNATIONAL JOURNAL OF STROKE (2018)

Add to Collection

Article Clinical Neurology

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

Nicola Logallo et al.

LANCET NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Tenecteplase in ischemic stroke offers improved recanalization Analysis of 2 trials

Andrew Bivard et al.

NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Alteplase versus tenecteplase for thrombolysis after Cross Mark ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study

Xuya Huang et al.

LANCET NEUROLOGY (2015)

Add to Collection

Article Public, Environmental & Occupational Health

Thrombolysis for acute ischemic stroke by tenecteplase in the emergency department of a Moroccan hospital

Ahmed Belkouch et al.

PAN AFRICAN MEDICAL JOURNAL (2015)

Add to Collection

Article Medicine, General & Internal

A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke

Mark Parsons et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Medicine, General & Internal

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Add to Collection

Article Clinical Neurology

Acute ischemic stroke Imaging-guided tenecteplase treatment in an extended time window

M. W. Parsons et al.

NEUROLOGY (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.